Quadrant Capital Group’s Veracyte VCYT Stock Holding History

Quadrant Capital Group’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.6K	Sell	298 -66	-18%	-$2.44K	﹤0.01%	2198
2025 Q4	$15.3K	Buy	364 +66	+22%	+$2.66K	﹤0.01%	2092
2025 Q3	$10.2K	Buy	+298	New	+$8.55K	﹤0.01%	2153
2025 Q2	–	Sell	-9	Closed	-$267	–	2578
2025 Q1	$267	Hold	9	–	–	﹤0.01%	2701
2024 Q4	$357	Hold	9	–	–	﹤0.01%	2670
2024 Q3	$307	Hold	9	–	–	﹤0.01%	2690
2024 Q2	$196	Hold	9	–	–	﹤0.01%	2664
2024 Q1	$200	Hold	9	–	–	﹤0.01%	2691
2023 Q4	$248	Hold	9	–	–	﹤0.01%	2658
2023 Q3	$201	Hold	9	–	–	﹤0.01%	2647
2023 Q2	$230	Hold	9	–	–	﹤0.01%	2647
2023 Q1	$201	Hold	9	–	–	﹤0.01%	2675
2022 Q4	$214	Hold	9	–	–	﹤0.01%	2694
2022 Q3	$0	Sell	9 -404	-98%	-$9.09K	﹤0.01%	2813
2022 Q2	$8K	Buy	+413	New	+$8.34K	﹤0.01%	1802

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Quadrant Capital Group's VCYT Position: Q1 2026 in Review

Quadrant Capital Group reduced its Veracyte (VCYT) stake by 18% in Q1 2026, selling an estimated $2.44K and leaving 298 shares worth $9.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

Quadrant Capital Group first reported a position in VCYT in Q2 2022 and has held it in 15 quarters since. The position peaked at $15.3K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

Quadrant Capital Group held 298 shares of Veracyte worth $9.6K as of Q1 2026.
Quadrant Capital Group sold 66 Veracyte shares in Q1 2026, an estimated $2.44K.
Veracyte made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2198 holding.
Quadrant Capital Group first reported a position in Veracyte in Q2 2022 and has held it in 15 quarters since.
Quadrant Capital Group's Veracyte position peaked at $15.3K in Q4 2025.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.